Meticulous Research® Unveils Latest Report: Molecular Diagnostics Market Projected to Reach $46.69 Billion by 2030

[Redding, California , 12-03-2024] - Meticulous Research®, a premier provider of comprehensive market research solutions, has released its latest report titled, "Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab) - Global Forecast to 2030." This groundbreaking report forecasts the molecular diagnostics market to soar to an estimated value of $46.69 billion by 2030, exhibiting a noteworthy CAGR of 5.6% from 2023 to 2030.

Driving Factors Behind Market Growth

The report attributes the robust growth of the molecular diagnostics market to several key factors, including the escalating global geriatric population, the surge in communicable and non-communicable diseases, continuous technological advancements in molecular diagnostics, and the escalating healthcare expenditures worldwide. Moreover, burgeoning opportunities in emerging economies, a growing emphasis on companion diagnostics, and the increasing popularity of direct-to-consumer (DTC) genetic testing are anticipated to fuel significant market expansion.

Download Free Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=5375

Rise in Molecular Diagnostics Approvals Amidst the COVID-19 Pandemic

During the unprecedented COVID-19 pandemic, manufacturers intensified efforts to develop diverse diagnostic kits and assays for early disease detection, projected to drive market growth in the forthcoming years. Notable developments during this period include:

In May 2022, Cepheid (a subsidiary of Danaher) (U.S.) obtained CE Mark for Xpert Xpress CoV-2 plus, a test for qualitative detection of COVID-19.

In May 2021, F. Hoffmann-La Roche Ltd (Switzerland) received Emergency Use Authorization (EUA) from the U.S. FDA for cobas SARS-CoV-2 test, designed for individuals without COVID-19 symptoms or suspicions.

In November 2020, BioMérieux S.A. (France) secured CE mark for the SARS-CoV-2 R-GENE test, a part of the ARGENE range for SARS-CoV-2 detection.

In September 2020, Hologic, Inc. (U.S.) received Emergency Use Authorization (EUA) from the U.S. FDA for asymptomatic COVID-19 testing with Panther Fusion SARS-CoV-2 Assay.

Browse in depth @ https://www.meticulousresearch.com/product/molecular-diagnostics-market-5375

Furthermore, companies operating in the diagnostics market conducted web meetings and webinars during this period to engage with customers and stakeholders, providing detailed product descriptions and customer demonstrations, thereby enhancing end-user awareness.

Market Segmentation and Growth Trends

The molecular diagnostics market is segmented based on Product & Service, Test Type, Technology, Application, End User, and Geography. Key insights include:

Product & Service: The kits & reagents segment is anticipated to hold the largest market share in 2023, driven by the frequent utilization of diagnostic kits, an extensive portfolio of disease-specific kits, and technological advancements.

Test Type: Laboratory tests are expected to dominate the market in 2023, preferred by hospitals, laboratories, and academic & research institutes.

Technology: PCR is projected to lead the market in 2023, owing to its sensitivity, rapid amplification capabilities, and cost-effectiveness compared to other technologies.

Application: Infectious diseases are forecasted to account for the largest market share in 2023, fueled by rising incidence rates and government initiatives promoting early diagnosis.

Request Free Research Report Sample: https://www.meticulousresearch.com/request-sample-report/cp_id=5375

End User: Hospitals & clinics are expected to hold the largest market share in 2023, attributed to their extensive range of diagnostic tests and patient volume.

Geographic Analysis

North America is anticipated to command the largest market share in 2023, followed by Europe and Asia-Pacific, driven by advanced infrastructure, favorable reimbursement policies, increased healthcare accessibility, and a high volume of laboratory tests.

Key Players

Leading players in the molecular diagnostics market include F. Hoffmann-La Roche Ltd, Hologic, Inc., QIAGEN N.V., Danaher Corporation, bioMérieux S.A., and Becton, Dickinson and Company (BD), among others.

Quick Buy @ https://www.meticulousresearch.com/Checkout/18320359

Contact:
Meticulous Market Research Pvt Ltd
Office No-202, 203,204,205,206
2nd Floor, Pushpak Business Hub,
Wakad, Pimpri-Chinchwad,
411057, India.
Phone: +9102066394988
CIN- U93000PN2013PTC149455

We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition. Through our mixed bag of research offerings - syndicated research, custom research, and analyst engagement - we enable smart decision making to enhance business performance for global organizations. Our focus is also on finding answers to the challenging questions that global business leaders face on a daily basis. Each year, we deliver more than 300 syndicate studies and 60+ consulting projects across eight industry verticals in 20+ geographic markets.

This release was published on openPR.